SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY. (17th June 2021) - Lim, S.H.; Campbell, N.; Joseph‐Pietras, D.; Johnson, M.; Mundy, C.; Coleman, H.; Wynn, T.; Maynard, B.; Lown, R.; Bates, A.; Wetherall, N.; Muller, D.; et al.